What's New:iOS App Released + New 2026 Model Update
S
Superday AI
Sunday ScariesMay 17, 2026

Vol. 4 · Week of May 17, 2026

Sunday Scaries Vol. 4

Kevin Warsh takes the Fed chair on the weakest Senate vote since 1977, Goldman's advisory fees jump 89%, and AMETEK is buying Indicor's Instrumentation arm for $5B. Five-minute recap before Monday.

Welcome back. Kevin Warsh has the Fed after the weakest Senate vote for a chair since 1977, the M&A supercycle finally has hard numbers behind it, and Trump and Xi met in Beijing and left without a trade deal. Five minutes, every section, ammo for Monday.

Top Stories of the Week

1. Warsh has the Fed. It was the weakest Senate support for a chair since 1977.

The Senate confirmed Kevin Warsh as the 17th Fed chair on May 13 in a 54-45 vote, the weakest support for the role since it became Senate-confirmed in 1977 (the prior low was Yellen's 56 votes in 2014). Powell's chair term expired May 15; he keeps a Board seat, but Warsh now runs the FOMC. Inflation has run above the 2% target for more than five years, now compounded by tariffs and high oil prices. Markets see rates holding at 3.50 to 3.75% through year-end 2026. Warsh has signaled inflation-first discipline and "messier," more deliberative meetings, meaning less forward guidance and more meeting-to-meeting volatility on rate expectations.

Why you care: The chair sets the cost of debt under every LBO and leveraged acquisition. An inflation-first chair with no bias toward cuts changes how sponsor coverage underwrites returns and how leveraged finance desks size high-yield capacity.

Interview angle: "With Warsh prioritizing inflation discipline over cuts, acquirers are stress-testing models on more conservative financing assumptions. That compresses LBO returns and pushes sponsors toward equity-heavy structures or seller financing."

2. The M&A supercycle has numbers now. Goldman's advisory fees jumped 89%.

The 2026 supercycle thesis has hard evidence. Goldman reported Q1 advisory revenue up 89% year-over-year, with total IB fees up 48% to $2.84B. Morgan Stanley posted IB revenue up 36% to $2.12B, and its Institutional Securities division logged record net revenues. The backdrop held: the S&P 500 made fresh record highs midweek, closing above 7,500 on May 13, and April payrolls came in at 115,000 against the Dow Jones consensus of 55,000, a second straight monthly gain and the first back-to-back payroll growth in nearly a year. Healthcare and natural-resources deal flow accelerated through May, with industrials re-engaging.

Why you care: Surging advisory fees mean more deal teams, more analyst hiring, and bigger bonus pools. Interviewers will probe whether you understand why activity is up, not just that it is.

Interview angle: "Three tailwinds are converging: near-record equity markets giving strategics strong acquisition currency, PE firms under pressure to return DPI after long holds, and a more permissive regulatory posture cutting deal-certainty risk."

3. Trump and Xi met in Beijing. They left without a trade deal.

Trump and Xi met May 14-15 in Beijing, the first sitting U.S. president there in nearly a decade. The summit produced no major tariff rollback, just a proposed "managed trade" mechanism that would cover roughly $30B of goods, discussed but not enacted. U.S. tariffs on Chinese goods still sit around 30% headline, down from last year's 145% peak, and two-way goods trade fell to about $415B in 2025 (from $582B in 2024 and a $690B peak in 2022). The S&P 500 fell 1.24% on Friday, its steepest day since late March, with the disappointing summit one driver alongside rising Treasury yields.

Why you care: Trade policy is a live input in every cross-border model. Targets with China supply-chain exposure carry heavier diligence, valuation uncertainty, and regulatory risk a first-year flags in the deal memo.

Interview angle: "On cross-border targets with China manufacturing exposure, buyers now run higher tariff scenarios as the base case, not a tail risk. That moves EBITDA margin assumptions and the entry multiple."

Deals of the Week

AMETEK buys Indicor's Instrumentation business from CD&R, about $5.0B. All-cash, announced May 6, closing expected in the second half of 2026. CD&R took majority control (51%) of Roper's industrial portfolio, later branded Indicor, back in 2022 at a reported ~$3.6B enterprise value, putting in roughly $2.6B upfront cash while Roper rolled a 49% stake. Selling just the Instrumentation arm (~$1.1B in annual sales) for ~$5B lets CD&R recover roughly its entire original cash outlay while keeping the rest of Indicor. That is the sponsor carve-out playbook.

  • AMETEK advisors: AMETEK did not disclose financial or legal advisors.
  • CD&R / Indicor advisors: Debevoise & Plimpton (legal, to sellers CD&R and Indicor). No sell-side financial advisor disclosed.

VSE Corporation buys Precision Aviation Group from GenNx360, ~$2.025B. Announced January 29, closed May 5. About $2.025B upfront ($1.75B cash plus roughly $275M in VSE-exchangeable equity to GenNx360), with up to $125M more in earnout tied to PAG's 2026 EBITDA. A clean sponsor exit in aviation aftermarket and MRO services. Note the structure: Perella Weinberg ran both M&A and debt capital markets for VSE, with RBC lead-left on the Term Loan B.

  • VSE advisors: Perella Weinberg Partners (exclusive financial and debt capital markets advisor); RBC Capital Markets (lead-left arranger, Term Loan B); Jones Day (legal)
  • GenNx360 / Precision Aviation advisors: J.P. Morgan, Jefferies (financial); Winston & Strawn (legal)

Pro tip: Pick one and know it cold by Friday. AMETEK/Indicor is your carve-out and partial-exit math story. VSE/Precision Aviation is your clean sponsor-exit story, with a bonus on how mid-market mandates bundle M&A and financing advisory. One you can speak to fluently beats three you skimmed.

Recruiting Pulse

AI fluency is a superday expectation, not a differentiator. Candidates we talk to describe AI-specific screening that did not exist 12 months ago: audit an AI-generated comps set, or validate a model output before it goes to an MD. Tool fluency is table stakes. The separator is knowing where AI breaks in a financial context, because hallucinated multiples and misread footnotes are real failure modes. If you cannot name AI's limits in modeling, you are behind peers who can.

Goldman's rolling performance cuts are reshaping analyst culture. Goldman reportedly replaced its year-end class-wide cull with rolling, performance-based cuts starting in April. Recent grads tell us this redistributes pressure across the whole year instead of one annual review. Peers at other bulge brackets say their firms are tracking the model. Practically: summer performance is judged on tighter tolerances, and one rough week in August carries more weight than it used to.

Record hiring classes, record-low acceptance rates. UK banks plan 2,365 graduate hires in 2026, up from the 2,069 they actually took in 2025, the strongest intake in years, but applications are rising faster than headcount. Goldman and JPMorgan early-careers acceptance rates have dropped below 1% (roughly 0.7% and 0.8%). Candidates tell us per-student application volume is at an all-time high, partly because AI tools make mass-applying trivial. The resume screen is increasingly automated, so the decisions that matter happen in referral pipelines, not portals. Build the relationship before the portal opens.

AI-Powered Interview Prep

Want this in your inbox every Sunday?

Free. Five minutes. Built for college students who want the IB news that actually moves recruiting forward.

More Sunday Scaries

Ready to ace your interview?

The #1 AI prep tool for investment banking interviews

Built by Wall Street insiders and used on 50+ campuses. Practice until you're ready — not until you run out of flashcards.

Try Free Today

1,500+ Drills

Technical questions with instant feedback

Mock Interviews

AI-powered realistic interview practice

AI Coaching

Personalized prep plans for your target banks

Resume Analyzer

Score your candidacy against real data